Skip to content

Clinical trials

Inflammatory Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20022
20037
20042
20056
20067
20077
20082
20095
20103
20113
20123
20134
20144
20153
20163
20176
20184
20193
20201
20213
20224
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated17
Unknown status16
Active, not recruiting14
Recruiting6
Withdrawn4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center17
National Cancer Institute (NCI)11
City of Hope Medical Center6
GBG Forschungs GmbH5
Dana-Farber Cancer Institute4
European Organisation for Research and Treatment of Cancer - EORTC4
RenJi Hospital3
Alliance for Clinical Trials in Oncology2
Auxilio Mutuo Cancer Center2
Duke University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms112
Breast Neoplasms84
Breast Neoplasms, Male13
Triple Negative Breast Neoplasms13
Carcinoma, Ductal, Breast11
Carcinoma, Lobular6
Breast Carcinoma In Situ5
Bile Duct Neoplasms4
Carcinoma, Hepatocellular4
Carcinoma, Non-Small-Cell Lung4

Trials

Showing 76 to 100 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.